ReviewBreast (Edinburgh, Scotland)2026

Neurokinin pathway antagonists for vasomotor symptoms in women with breast cancer: focus on elinzanetant and fezolinetant.

Katarzyna Pogoda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.